Special webinars

Optimising Outcomes with Pre-Transplant Treatment Selection in high-risk AML*
This symposium was organised during IACH 2020 and funded by Jazz Pharmaceuticals for healthcare professionals only

COVID 19 ONE YEAR LATER, NOT THE END YET
Prof. NC Gorin, Prof. Jean Philippe Deslys, Prof. Bruno Canard, Prof. Patrick Berche

Prevention & treatment of major infectious diseases in hematology/oncology patients in the COVID era
Prof. NC Gorin, Prof. Rafael Duarte, Prof. Huang He, Prof. Arnaud Fontanet

Optimal management of GVHD: an update (webinar in French)
Prof. Florent Malard

IACH Webinars dedicated to the COVID-19 pandemic

The COVID-19 pandemic emergency and young physicians: life before and after the crisis?
Carolina Marini, Mohamad Mohty

The COVID-19 pandemic emergency and hematology: reporting live from the ICU
Giovanni Landoni, Mohamad Mohty

The COVID-19 pandemic emergency and management of acute leukemia: challenges and options
Naveen Pemmaraju, Mohamad Mohty

The COVID 19 pandemic emergency and hematology a psychologist perspective
Yolande Arnault, Mohamad Mohty

The COVID-19 pandemic emergency and the ethics of research
Philippe Gabriel Steg, Mohamad Mohty

A COVID-19 personal experience: when a hematologist becomes a patient as well as caregiver
Noopur Raje, Mohamad Mohty

The COVID-19 pandemic emergency and hematology: experience and perspectives from Italy
Mohamad Mohty, Annalisa Ruggeri

Management of multiple myeloma during COVID 19
Prof. Mohty, Prof. Mateos

COVID-19 and hematological malignancies: a few practical issues
Prof. Mohty, Prof. Chabannon

*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)
This symposium is organised and funded by Jazz Pharmaceuticals for healthcare professionals only